Nihon Seiko Co., Ltd. (5729.T)
Tokyo, JP
Nihon Seiko Co., Ltd., a Tokyo-based company founded in 1935 and known as Nakase Kogyo Co., Ltd. until 1936, is a key Japanese producer and distributor of antimony products and various metal powders. Their diverse antimony-based offerings include antimony trioxide, which functions as a flame retardant in plastics and rubbers, a catalyst for polyester production, and a solid lubricant in brake pads. Antimony metal is supplied for essential uses in semiconductors, optical memory disk films, thermoelectric converters, storage batteries, bearing metals, and a range of specialized alloys for applications such as hard lead castings, cable sheathing, typemetals, sheets, and pipes. The company also provides antimony in metal powder and shot forms, primarily for glass fining agents and alloy manufacturing. A unique blend of copper and antimony metal powder is specifically formulated for electric detonators. Their catalog extends to specialized antimony compounds: 'special treatment' antimony trioxide, and sodium antimonate, which is incorporated into engineering plastics and aids in glass decolorization and fining. Antimony trisulfide is employed in friction materials, matchbox flints, fireworks, glass fining, toys, and flash mixtures. Antimony pentasulfide is utilized for surface treatments on decorative trims and building materials. Nihon Seiko further supplies antimony trichloride and pentachloride, serving as catalysts for fluorination, chlorination, and bromination of organic compounds, and as components in pigments and semiconductor materials. Additionally, their STEM series comprises pre-blended flame retardants designed for polyolefin plastics like polypropylene (PP) and polyethylene (PE). Beyond its extensive antimony portfolio, the company manufactures atomized metal powders from a broad spectrum of materials, including copper, tin, bronze, brass, silver, platinum, gold, stainless steel, nickel, and various nickel alloys.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.93% | -19.07% | -28.29% | -33.20% | -25.15% | -29.92% | +54.05% | +160.12% | +165.72% | +376.53% | +505.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+62.3% ★ Q1'26: +19.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+71.4% ★ Q1'26: -107.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+16.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+14.9% ★ Q1'26: -2.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%+37.0% ★ Q1'26: -4.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.1% Q1'26: -0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.41× ★ Q1'26: -13.26× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
|---|---|---|---|---|---|
| Revenue |
14.40B
est.
|
15.00B
est.
|
10.91B
est: 12.40B (-12.0%)
|
11.25B
est: 12.80B (-12.1%)
|
17.10B
est: 13.20B (+29.5%)
|
| EBITDA |
1.83B
est.
|
1.90B
est.
|
904.00M
est: 1.57B (-42.5%)
|
1.61B
est: 1.62B (-0.8%)
|
2.72B
est: 1.67B (+62.4%)
|
| EBIT |
1.37B
est.
|
1.43B
est.
|
448.00M
est: 1.18B (-62.1%)
|
1.20B
est: 1.22B (-2.0%)
|
2.26B
est: 1.26B (+79.5%)
|
| Net Income |
1.00B
est.
|
962.12M
est.
|
286.00M
est: 651.44M (-56.1%)
|
813.68M
est: 751.50M (+8.3%)
|
1.54B
est: 801.64M (+92.2%)
|
| SGA |
940.96M
est.
|
980.17M
est.
|
928.00M
est: 810.27M (+14.5%)
|
908.00M
est: 836.41M (+8.6%)
|
1.08B
est: 862.55M (+24.7%)
|
| EPS |
409.60
est.
|
393.30
est.
|
29.30
est: 266.30 (-89.0%)
|
83.35
est: 307.20 (-72.9%)
|
157.86
est: 327.70 (-51.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Responsible International Equity ETF AVSD | 0.00% | 7.6K | 0.23% |
| 2 | Avantis International Small Cap Value ETF AVDV | 0.00% | 24.1K | 0.36% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kyouji Matsuda | Sales Manager & Director | — | male |
| Noritaka Ueda | President, Chief Executive Officer & Director | — | male |
| Takenori Wakabayashi | Senior MD & Director | — | male |
| Takeshi Ogi | Accounting Department Manager | — | — |
| Yoshitaro Oonishi | GM of Planning & Management Department and Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5729.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
